您当前的位置：
首页 >
文章列表页 >
Clinical Efficacy and Safety of Qingyusan Capsules in Treatment of Ulcerative Colitis with Syndrome of Large Intestine Dampness-heat
更新时间：2024-06-14

    • Clinical Efficacy and Safety of Qingyusan Capsules in Treatment of Ulcerative Colitis with Syndrome of Large Intestine Dampness-heat

    • “The latest research shows that Qingyu San capsules have significant efficacy and good safety in the treatment of mild to moderate active ulcerative colitis. Through a randomized controlled study, the clinical remission rate and mucosal healing rate of the Qingyu San group were significantly higher than those of the control group, while improving traditional Chinese medicine syndromes and patient quality of life. This study provides a new solution for the treatment of ulcerative colitis.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 14, Pages: 114-121(2024)

    • DOI：10.13422/j.cnki.syfjx.20241698    

      CLC： R242;R22;R2-031;R289;R574.62;R714.255;R256.3

    • Received：09 January 2024，

      Published Online：28 May 2024，

      Published：20 July 2024

    移动端阅览

  • LIU Xiaowen,GU Sizhen,DOU Danbo,et al.Clinical Efficacy and Safety of Qingyusan Capsules in Treatment of Ulcerative Colitis with Syndrome of Large Intestine Dampness-heat[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(14):114-121. DOI： 10.13422/j.cnki.syfjx.20241698.

  •  
  •  

0

Views

30

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Chinese Medicine Regulates Intestinal Flora to Treat Ulcerative Colitis in Patients with Syndrome of Large Intestine Dampness-heat： A Review
Mechanisms of Zhuyuwan in Treating both Intrahepatic Cholestasis and Ulcerative Colitis Based on Homotherapy for Heteropathy
Shaoyaotang Containing Serum Mediates Fas/FasL Pathway to Inhibit Lipopolysaccharide Induced Inflammation and Apoptosis of Caco-2 Cells
Shaoyaotang Restores Th17/Treg Cell Balance by Regulating Glucose Metabolism Reprogramming in Treatment of Ulcerative Colitis

Related Author

LONG Jingyi
LIANG Aihua
HAN Jun
WEN Yueqiang
XU Zongying
LUO Dan
ZHOU Li
LI Xueyi

Related Institution

School of Traditional Chinese Medicine，Tianjin University of Traditional Chinese Medicine
Key Laboratory of Beijing for Identification and Safety of Chinese Medicine，Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences
School of Basic Medical Sciences， Chengdu University of Traditional Chinese Medicine（TCM）
School of Basic Medical Sciences， Guangzhou University of Chinese Medicine
Deng Zhongjia Inheritance Studio，Chengdu University of TCM
0